HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRODUCTIVE INFECTION IN STAUROSPORINE-BLOCKED QUIESCENT CELLS

被引:2
|
作者
ARANDAANZALDO, A
VIZA, D
机构
[1] URA-CNRS, Laboratoire d'Immumobiologie, Facultè de Mèdecine, 75006 Paris, 45, rue des Saints-Pères
关键词
PROTEIN KINASE INHIBITOR; VIRAL INFECTIVITY; CELL CYCLE; T-CELL;
D O I
10.1016/0014-5793(92)81268-Q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Staurosporine, an antibiotic known to inhibit cellular protein kinases, can reversibly block the progress of normal and tumour cells into the cell cycle. The ability of HIV-1 to infect and replicate in cells blocked by staurosporine was investigated. The results show that blocked, non-cycling cells can be productively infected by HIV-1, steadily releasing infectious progeny virus for several weeks. This suggests that at least in some cases. HIV-1 can be found in a stable and active state in resting, non-proliferating T cells.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 50 条
  • [31] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN A COMMUNITY OF SOUTHERN MOZAMBIQUE
    MENCARINI, P
    DELUCA, A
    GHIRGA, P
    VICHI, F
    ANTINORI, A
    MAIURO, G
    NOORMAHOMED, I
    TAMBURRINI, E
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1991, 43 (1-2): : 39 - 41
  • [32] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [33] IGA NEPHROPATHY IN A CHILD WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    TRACHTMAN, H
    GAUTHIER, B
    VINOGRAD, A
    VALDERRAMA, E
    PEDIATRIC NEPHROLOGY, 1991, 5 (06) : 724 - 726
  • [34] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [35] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AND BREAST-MILK
    DEMARTINO, M
    TOVO, PA
    GALLI, L
    GABIANO, C
    ACTA PAEDIATRICA, 1994, 83 : 51 - 58
  • [36] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CANDIDATE VACCINE BREAKTHROUGH INFECTION
    MASCOLA, JR
    MCNEIL, JG
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06): : 1636 - 1637
  • [37] COMBINATION THERAPY FOR INFECTION DUE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CALIENDO, AM
    HIRSCH, MS
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) : 516 - 524
  • [38] MODULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF HUMAN MONOCYTES BY IGA
    JANOFF, EN
    WAHL, SM
    THOMAS, K
    SMITH, PD
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03): : 855 - 858
  • [39] SUSCEPTIBILITY OF CULTURED HUMAN TROPHOBLASTS TO INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ZACHAR, V
    NORSKOVLAURITSEN, N
    JUHL, C
    SPIRE, B
    CHERMANN, JC
    EBBESEN, P
    JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 1253 - 1260
  • [40] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CAUSES PRODUCTIVE INFECTION OF MACROPHAGES IN PRIMARY PLACENTAL CELL-CULTURES
    MCGANN, KA
    COLLMAN, R
    KOLSON, DL
    GONZALESSCARANO, F
    COUKOS, G
    COUTIFARIS, C
    STRAUSS, JF
    NATHANSON, N
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04): : 746 - 753